TRUE AHF

Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decompensated Heart Failure

Stage: klaar
Medicine: Urodilatin (Ularitide)
Population: Hartfalen
Phase: III
First Patient In: 1 January 2012
Last Patient In: 13 May 2015
Last Patient Last Visit: -

Study Director

drs. F.R. den Hartog

Cardioloog